3515 LYMAN BOULEVARD, CHASKA, MN
Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update
Lifecore Biomedical, Inc. Announces Redemption of Series A Preferred Stock
Approval of Lifecore Biomedical, Inc. 2026 Stock Incentive Plan
Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update
Shareholder Director Nominations
Lifecore Biomedical, Inc. Adopts Incentive Bonus Plan for Executives
Investor Presentation
Q1
Q3
Annual Report Transition
FY 2025
Q2
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload